login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
NKARTA INC (NKTX) Stock News
NASDAQ:NKTX -
US65487U1088
-
Common Stock
2.37
USD
+0.05 (+2.16%)
Last: 8/22/2025, 8:27:16 PM
2.37
USD
0 (0%)
After Hours:
8/22/2025, 8:27:16 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NKTX Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: The Motley Fool
Nkarta Posts Narrower Loss in Q2
12 days ago - By: Nkarta, Inc.
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights
12 days ago - By: Nkarta, Inc.
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights
a year ago - By: The Motley Fool
- Mentions:
RJF
Why Nkarta Stock Is Soaring Today
a year ago - By: BusinessInsider
NKTX Stock Earnings: Nkarta Beats EPS for Q2 2024
a month ago - By: Nkarta, Inc.
Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series
3 months ago - By: Nkarta, Inc.
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
3 months ago - By: Nkarta, Inc.
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
3 months ago - By: Zacks Investment Research
Nkarta (NKTX) Moves to Buy: Rationale Behind the Upgrade
3 months ago - By: Benzinga
Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space
a year ago - By: InvestorPlace
NKTX Stock Earnings: Nkarta Beats EPS for Q2 2024
3 months ago - By: Benzinga
- Mentions:
AA
GROV
COLD
LAZR
This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
3 months ago - By: Nkarta, Inc.
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
3 months ago - By: Nkarta, Inc.
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
4 months ago - By: Zacks Investment Research
Nkarta (NKTX) Upgraded to Buy: Here's Why
5 months ago - By: Nkarta, Inc.
Nkarta to Participate in an April Investor Conference
5 months ago - By: Nkarta, Inc.
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
5 months ago - By: Nkarta, Inc.
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
6 months ago - By: Nkarta, Inc.
Nkarta to Participate in March Investor Conferences
9 months ago - By: Nkarta, Inc.
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
9 months ago - By: Nkarta, Inc.
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
9 months ago - By: Nkarta, Inc.
Nkarta to Participate in an Upcoming Investor Conference
10 months ago - By: Nkarta, Inc.
Nkarta to Participate in an Upcoming Investor Conference
10 months ago - By: Nkarta, Inc.
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
10 months ago - By: Nkarta, Inc.
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
a year ago - By: Nkarta, Inc.
Nkarta to Participate in Upcoming Investor Conference
a year ago - By: Nkarta, Inc.
Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
a year ago - By: Nkarta, Inc.
Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
Please enable JavaScript to continue using this application.